Generation Bio Co. (GBIO)
Feb 9, 2026 - GBIO was delisted (reason: acquired by XOMA)
5.34
-0.40 (-6.97%)
Inactive · Last trade price
on Feb 6, 2026
Generation Bio Co. Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Generation Bio Co. stock had an average target of 8.88, with a low estimate of 5.00 and a high estimate of 15.
Analyst Consensus: Buy
* Price targets were last updated on Dec 16, 2025.
Analyst Ratings
The average analyst rating for Generation Bio Co. stock from 5 stock analysts was "Buy". This means that analysts believed this stock was likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Hold → Buy Upgrades $7 → $5.5 | Hold → Buy | Upgrades | $7 → $5.5 | +3.00% | Dec 16, 2025 |
| Jefferies | Jefferies | Strong Buy → Hold Downgrades $11 → $5 | Strong Buy → Hold | Downgrades | $11 → $5 | -6.37% | Dec 16, 2025 |
| Needham | Needham | Strong Buy Suspends $15 | Strong Buy | Suspends | $15 | +180.90% | Nov 7, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $9 → $10 | Strong Buy | Maintains | $9 → $10 | +87.27% | Aug 18, 2025 |
| Needham | Needham | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +180.90% | Aug 13, 2025 |
Financial Forecast
Revenue This Year
11.21M
from 19.89M
Decreased by -43.64%
Revenue Next Year
n/a
from 11.21M
EPS This Year
-13.25
from -19.76
EPS Next Year
-5.99
from -13.25
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 12.9M | n/a | ||||
| Avg | 11.2M | n/a | ||||
| Low | 9.3M | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -35.1% | - | ||||
| Avg | -43.6% | - | ||||
| Low | -53.2% | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -12.63 | -0.27 | |
| Avg | -13.25 | -5.99 | |
| Low | -13.66 | -12.09 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.